Literature DB >> 9128108

Acute respiratory illnesses in the first 18 months of life.

I M López Bravo1, H Sepúlveda, I Valdés.   

Abstract

To help assess the causes and frequency of acute respiratory illnesses (ARI) during the first 18 months of life in Chile, a cohort of 437 children born in good health between May 1991 and April 1992 was followed at an urban health clinic in northern Santiago. Information was obtained from medical checkups performed at the clinic, from emergency health care services, from private physicians, and from interviews with each child's mother when the child was enrolled in the study and when it was 6, 12, and 18 months old. Followup was completed for 379 (87%) of the children. ARI accounted for 67% of all 3762 episodes of illness recorded for these children in the 18-month study period, 1384 (55%) of the ARI episodes affecting the upper respiratory tract and the remaining 1144 (45%) affecting the lower. The overall rate of ARI observed was 33 episodes per 100 child-months of observation. The incidences of upper, lower, and total ARI episodes decreased significantly in the third six months of life. A statistically significant association was found between upper ARI (> or = 2 episodes) and maternal smoking (> or = 5 cigarettes per day), but no significant associations were found with any of the other risk factors studied. However, lower ARI (> or 2 episodes) was significantly associated with maternal schooling (< 8 years), a family history of atopic allergy, and substandard housing conditions; and lower ARI (> or = 4 episodes) was significantly associated with these factors and also with the existence of one or more siblings, birth in a cold season, limited breast-feeding (< 4 months), and low socioeconomic status. Significant associations were found between obstructive bronchitis episodes and most of the risk factors studied (gender, siblings, season of birth, duration of breast-feeding, maternal schooling, smoking, use of polluting fuels in the home, and a family history of atopic allergy); similarly, significant associations were found between the occurrence of pneumonia and many risk factors (including siblings, season of birth, duration of breast-feeding, maternal schooling, smoking, and socioeconomic level). Overall, 42 of the study children were hospitalized during the study period for lower tract ARI, and two children died of pneumonia at home during their first 6 months of life. The rate of hospitalization fell significantly with increasing age.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9128108     DOI: 10.1590/s1020-49891997000100003

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  5 in total

1.  Burden of acute respiratory infections in a family cohort in Iran.

Authors:  M Naghipour; C A Hart; L E Cuevas
Journal:  Epidemiol Infect       Date:  2007-02-21       Impact factor: 2.451

2.  Nutritional predictors of acute respiratory infections among children born to HIV-infected women in Tanzania.

Authors:  Ramadhani Mwiru; Donna Spiegelman; Ellen Hertzmark; Christopher Duggan; Gernard Msamanga; Said Aboud; Wafaie Fawzi
Journal:  J Trop Pediatr       Date:  2013-02-11       Impact factor: 1.165

Review 3.  Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean: a systematic review and meta-analysis, 1990-2010.

Authors:  Elizabeth Castañeda; Clara Inés Agudelo; Rodrigo De Antonio; Diego Rosselli; Claudia Calderón; Eduardo Ortega-Barria; Rómulo E Colindres
Journal:  BMC Infect Dis       Date:  2012-05-28       Impact factor: 3.090

4.  Cohort profile: the Bern infant lung development cohort.

Authors:  Oliver Fuchs; Philipp Latzin; Claudia E Kuehni; Urs Frey
Journal:  Int J Epidemiol       Date:  2011-01-13       Impact factor: 7.196

5.  Influence of socio-economic and demographic factors in determining breathing patterns: a pilot study.

Authors:  Valdenice Aparecida de Menezes; Rossana Barbosa Leal; Marcela Motta Moura; Ana Flávia Granville-Garcia
Journal:  Braz J Otorhinolaryngol       Date:  2007 Nov-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.